Assetmark Inc. Has $1.52 Million Holdings in Koninklijke Philips N.V. (NYSE:PHG)

Assetmark Inc. increased its stake in shares of Koninklijke Philips N.V. (NYSE:PHG) by 1.7% during the first quarter, HoldingsChannel.com reports. The fund owned 59,806 shares of the technology company’s stock after purchasing an additional 982 shares during the period. Assetmark Inc.’s holdings in Koninklijke Philips were worth $1,519,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Northern Trust Corp boosted its position in Koninklijke Philips by 36.6% during the fourth quarter. Northern Trust Corp now owns 1,608,749 shares of the technology company’s stock worth $40,734,000 after purchasing an additional 430,757 shares during the period. GAMMA Investing LLC lifted its stake in shares of Koninklijke Philips by 3,094.8% in the first quarter. GAMMA Investing LLC now owns 350,241 shares of the technology company’s stock worth $8,896,000 after buying an additional 339,278 shares during the last quarter. Causeway Capital Management LLC lifted its stake in shares of Koninklijke Philips by 24.0% in the fourth quarter. Causeway Capital Management LLC now owns 1,566,850 shares of the technology company’s stock worth $39,673,000 after buying an additional 303,428 shares during the last quarter. Hsbc Holdings PLC bought a new stake in shares of Koninklijke Philips during the 4th quarter worth $3,039,000. Finally, Timber Creek Capital Management LLC grew its stake in Koninklijke Philips by 512.5% in the 1st quarter. Timber Creek Capital Management LLC now owns 105,185 shares of the technology company’s stock valued at $2,672,000 after buying an additional 88,012 shares during the last quarter. 13.67% of the stock is owned by institutional investors.

Koninklijke Philips Price Performance

Shares of NYSE:PHG opened at $26.80 on Thursday. The company has a market cap of $25.81 billion, a price-to-earnings ratio of 141.05, a PEG ratio of 0.81 and a beta of 0.76. The business has a 50 day moving average price of $23.89 and a 200 day moving average price of $24.97. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 0.60. Koninklijke Philips N.V. has a twelve month low of $21.48 and a twelve month high of $32.91.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings results on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.12. The company had revenue of $5.05 billion during the quarter, compared to analyst estimates of $4.35 billion. Koninklijke Philips had a return on equity of 11.67% and a net margin of 1.00%. Research analysts predict that Koninklijke Philips N.V. will post 1.63 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, July 12th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.